Concepedia

Thomas Sandal

TS

7

Publications

490

Citations

7

H-Index

1995

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Thomas Sandal is an author at Novo Nordisk (Denmark) specializing in biotechnology, microbiology, and biochemistry.

Top concepts

Publications per year

1995–2020

7

Publications

7

Comparison of expression systems in the yeastsSaccharomyces cerevisiae, Hansenula polymorpha, Klyveromyces lactis, Schizosaccharomyces pombe andYarrowia lipolytica. Cloning of two novel promoters fromYarrowia lipolytica

Sven Müller, Thomas Sandal, Peter Kamp‐Hansen et al. · Yeast · 1998 · 233 citations

, , +12

Increased Tumor Penetration of Single-Domain Antibody–Drug Conjugates Improves <i>In Vivo</i> Efficacy in Prostate Cancer Models

Ian Nessler, Eshita Khera, Steven Vance et al. · Cancer Research · 2020 · 118 citations · Full text

Expression cloning, purification and characterization of a β-1,4-glactanase from Aspergillus aculeatus

Stephan Christgau, Thomas Sandal, Lene V. Kofod et al. · Current Genetics · 1995 · 53 citations

Cloning and characterization of an endo-β-1,3(4)glucanase and an aspartic protease from Phaffia rhodozyma CBS 6938

Marie‐Louise Bang, I.S. Villadsen, Thomas Sandal · Applied Microbiology and Biotechnology · 1999 · 29 citations

, , +9

Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse

Yumin Teng, Joyce L. Young, Bryan Edwards et al. · New Biotechnology · 2019 · 29 citations · Full text

Rows per page

1–5 of 7